Linked from

The 68 pages that link to Pharmacogenomics, each with the reason it gives.

• GlucuronidationRelated: Variation in glucuronidation enzymes can alter drug exposure and effects.

• TranscriptomicsRelated: Expression profiles can help explain how cells respond to drug exposure and resistance.

• DNA microarrayRelated: Genotyping arrays can identify variants associated with drug response.

• Genetic epidemiologyRelated: Population evidence identifies genetic differences that can guide medication choices.

• Molecular pathologyRelated: Inherited variants can explain drug toxicity or guide dose selection.

• Mood stabilizerRelated: Genetic tests may clarify some medication risks, but they do not yet reliably choose a mood stabilizer.

• Clinical pharmacologyRelated: Genetic differences can alter metabolism, efficacy, and the dose a patient needs.

• TamoxifenNarrower topic: It frames ongoing debate about using CYP2D6 results to guide tamoxifen treatment.

• Human genomeRelated: Genomic variants can help explain differences in drug response.

• Medical testRelated: Genetic tests can help predict drug response and guide treatment choices.

• TramadolRelated: CYP2D6 variants help explain differences in tramadol’s opioid effects and adverse risks.

• Genetic admixtureRelated: Admixed populations can reveal ancestry-linked variation relevant to drug response.

• VardenafilNarrower topic: Inherited variation in aldehyde dehydrogenase 2 can affect vardenafil’s effects in some populations.

• Biological factorsRelated: It applies genetic differences to predicting drug efficacy and adverse effects.

• Diabetes medicationRelated: Genetic predictors could eventually help explain why diabetes drugs work differently across individuals.

• FluorouracilRelated: Inherited variation in fluoropyrimidine metabolism can alter fluorouracil toxicity.

• Molecular medicineRelated: It uses genetic differences to help predict drug response and guide treatment choices.

• Nutritional and Metabolic DiseasesRelated: Some metabolic disorders require treatments whose safety or effectiveness depends on genetic variants.